PHARMACY

Teva Pharmaceuticals to appeal ruling on Prevacid patent

BY Drew Buono

North Wales, Pa. Teva Pharmaceuticals plans to appeal a district court ruling that stated it failed to prove that the ‘098 patent on Takeda’s acid reflux disease drug Prevacid is invalid or unenforceable.

Takeda Pharmaceutical sued Teva in the U.S. District Court for the District of Delaware after Teva filed an application for a generic version of Tap Pharmaceutical’s Prevacid delayed-release capsules. Takeda and Abbott Laboratories recently decided to conclude the Tap joint venture, with Takeda retaining the rights to Prevacid.

At trial last year, Teva argued that Takeda’s ‘098 and ‘321 patents are invalid due to obviousness and that the ‘098 patent is unenforceable due to inequitable conduct, according to the March 31 opinion. Teva conceded that its proposed generic would infringe on the ‘098 patent, while Takeda argued that it also would infringe on the ‘321 patent.

The ‘098 patent covers Prevacid and expires in May 2009. The ‘321 patent, which covers combining Prevacid with magnesium carbonate to stabilize the compound, will expire this September.

Prevacid had sales in 2007 of over $3.3 billion according to the Food and Drug Administration.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Teva pays $7.5 million to settle IVAX lawsuit with Depomed

BY Drew Buono

MENLO PARK, Calif. Depomed will receive a one-time payment of $7.5 million from Teva Pharmaceuticals generic unit IVAX in relation to a settlement of a patent lawsuit, according to published reports.

Depomed had sued IVAX in January 2006 claiming patent infringement by IVAX’s Glucophage XR, a diabetes medication.

Under the terms of the settlement, Depomed will also get up to $2.5 million in royalties, for granting Teva a non-exclusive license allowing it to continue marketing the generic version of Glucophage XR.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

SynaMed launches free online PHR

BY Drew Buono

NEW YORK SynaMed has launched its free online personal health record, which will be available to all patients.

“SynaMed simplifies record keeping so that patients do not have to rely on memory. A personal health record can also provide lifesaving medical information when a patient is not able to speak for themselves,” according to Holly DeMuro, SynaMed’s director of operations. SynaMed’s personal health record system uses a Web browser-based application service provider model, which allows patients access anytime, from anywhere with Internet connection.

Patients using SynaMed’s personal health record will be able to record all of their medical history, doctor’s visits, check insurance coverage for medications, and receive health maintenance reminders about wellness issues and checkups. “Going forward, SynaMed will be expanding the Personal Health Record to include overall health information such as mood, weight, diet, and exercise trackers. This feature will be the first complete online wellness center,” DeMuro said.

In addition to a state of the art PHR, SynaMed offers a free fully integrated electronic medical record and practice management system to medical practitioners.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?